Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.37
-0.1000-1.83%
Post-market: 5.370.00000.00%19:30 EDT
Volume:1.90M
Turnover:10.21M
Market Cap:306.35M
PE:-4.79
High:5.55
Open:5.51
Low:5.22
Close:5.47
52wk High:7.65
52wk Low:4.00
Shares:57.05M
Float Shares:36.92M
Volume Ratio:1.06
T/O Rate:5.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):1.01
ROE:-43.13%
ROA:-24.55%
PB:2.39
PE(LYR):5.32

Loading ...

Abeona Therapeutics Activates 8th ZEVASKYN Treatment Center in Florida

MT Newswires Live
·
Yesterday

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for Zevaskyn®

THOMSON REUTERS
·
Yesterday

Abeona Therapeutics Updates Investor Presentation at Conference

TIPRANKS
·
Yesterday

Abeona Therapeutics Management to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 02

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Abeona Therapeutics Sees Major Insider Move From Company Director

TIPRANKS
·
Sep 02

Abeona Therapeutics Director Mark Alvino Disposes of 15,000 Common Shares Worth $87,966

Reuters
·
Sep 02

Abeona Therapeutics Grants 13,300 Restricted Shares to Five New Hires Under NASDAQ Inducement Plan

Reuters
·
Sep 01

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 01

High Insider Ownership Growth Stocks To Watch In August 2026

Simply Wall St.
·
Aug 22

Abeona Therapeutics reports Q2 EPS (35c), consensus (25c)

TIPRANKS
·
Aug 17

Abeona Therapeutics is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 15

Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating

MT Newswires Live
·
Aug 14

Abeona Therapeutics, Inc. : Oppenheimer Cuts Target Price to $21 from $22

THOMSON REUTERS
·
Aug 14

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Abeona Therapeutics Down Nearly 15%, on Pace for Largest Percent Decrease Since April 2024

Dow Jones
·
Aug 13

Abeona Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Abeona Shares Fall on Swing to 2Q Loss, Lower-than-Expected Revenue

Dow Jones
·
Aug 13

MeiraGTx Q2 Revenue Jumps on Reogen License Revenue

Reuters
·
Aug 13